1. The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US population. (December 2021) Authors: Beyerlin, Kassidy; Jimenez, Rachel; Zangardi, Mark; Fell, Geoffrey G; Edmonds, Christine; Johnson, Andrew; Bossuyt, Veerle; Specht, Michelle; Mulvey, Therese M; Moy, Beverly; Ellisen, Leif W; Isakoff, Steven J; Bardia, Aditya; Spring, Laura M Journal: Journal of oncology pharmacy practice Issue: Volume 27:Number 8(2021) Page Start: 1883 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗